Genome-wide Association Study Identifies a Regulatory Variant of RGMA Associated With Opioid Dependence in European Americans

摘要

BackgroundOpioid dependence (OD) is at epidemic levels in the United States. Genetic studies can provide insight into its biology. MethodsWe completed an OD genome-wide association study in 3058 opioid-exposed European Americans, 1290 of whom met criteria for a DSM-IV diagnosis of OD. Analysis used DSM-IV criterion count. ResultsBy meta-analysis of four cohorts, Yale-Penn 1 (n?= 1388), Yale-Penn 2 (n?= 996), Yale-Penn 3 (n?= 98), and SAGE (Study of Addiction: Genetics and Environment) (n?= 576), we identified a variant on chromosome 15, rs12442183, nearRGMA, associated with OD (p?= 1.3?× 10?8). The association was also genome-wide significant in Yale-Penn 1 taken individually and nominally significant in two of the other three samples. The finding was further supported in a meta-analysis of all available opioid-exposed African Americans (n?= 2014 [1106 meeting DSM-IV OD criteria];p?= 3.0?× 10?3) from three cohorts; there was nominal significance in two of these samples. Thus, of seven subsamples examined in two populations, one was genome-wide significant, and four of six were nominally (or nearly) significant.RGMAencodes repulsive guidance molecule A, which is a central nervous system axon guidance protein. Risk allele rs12442183*T was correlated with higher expression of a specificRGMAtranscript variant in frontal cortex (p?= 2?× 10?3). After chronic morphine injection, the homologous mouse gene (Rgma) was upregulated in C57BL/6J striatum. Coexpression analysis of 1301 brain samples revealed thatRGMAmessenger RNA expression was associated with that of four genes implicated in other psychiatric disorders, includingGRIN1. ConclusionsThis is the first study to demonstrate an association ofRGMAwith OD. It provides a new lead into our understanding of OD pathophysiology.